Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FPR2 DNA Aptamers for Targeted Therapy of Wound Repair.
de Arriba MDC, Fernández G, Chacón-Solano E, Mataix M, Martínez-Santamaría L, Illera N, Carrión-Marchante R, Martín ME, Larcher F, González VM, Del Río M, Carretero M. de Arriba MDC, et al. Among authors: carrion marchante r. J Invest Dermatol. 2022 Aug;142(8):2238-2248.e8. doi: 10.1016/j.jid.2021.12.026. Epub 2022 Jan 1. J Invest Dermatol. 2022. PMID: 34979109 Free article.
Dependence of Induced Biological Damage on the Energy Distribution and Intensity of Clinical Intra-Operative Radiotherapy Electron Beams.
Colmenares R, Carrión-Marchante R, Martín ME, Salinas Muñoz L, García-Bermejo ML, Oller JC, Muñoz A, Blanco F, Rosado J, Lozano AI, Álvarez S, García-Vicente F, García G. Colmenares R, et al. Among authors: carrion marchante r. Int J Mol Sci. 2023 Jun 28;24(13):10816. doi: 10.3390/ijms241310816. Int J Mol Sci. 2023. PMID: 37445992 Free PMC article.
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME. Carrión-Marchante R, et al. Pharmaceutics. 2023 Apr 18;15(4):1273. doi: 10.3390/pharmaceutics15041273. Pharmaceutics. 2023. PMID: 37111758 Free PMC article.
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Klett-Mingo JI, et al. Among authors: carrion marchante r. Cancers (Basel). 2022 Dec 30;15(1):227. doi: 10.3390/cancers15010227. Cancers (Basel). 2022. PMID: 36612223 Free PMC article.
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.
Pinto-Díez C, Ferreras-Martín R, Carrión-Marchante R, Klett-Mingo JI, García-Hernández M, Pérez-Morgado MI, Sacristán S, Barragán M, Seijo-Vila M, Tundidor I, Blasco-Benito S, Pérez-Gómez E, Gómez-Pinto I, Sánchez C, González C, González VM, Martín ME. Pinto-Díez C, et al. Among authors: carrion marchante r. Mol Ther Nucleic Acids. 2022 Nov 15;30:553-568. doi: 10.1016/j.omtn.2022.11.009. eCollection 2022 Dec 13. Mol Ther Nucleic Acids. 2022. PMID: 36457699 Free PMC article.